Head of Investor Relations, Senior​/Executive Director

Generate:

Biomedicines is a new kind of therapeutics company – existing at the intersection of machine learning, biological engineering, and medicine – pioneering Generative Biology™ to create breakthrough medicines where novel therapeutics are computationally generated, instead of being discovered. The Company has built a machine learning-powered biomedicines platform with the potential to generate new drugs across a wide range of biologic modalities.

This platform represents a potentially fundamental shift in what is possible in the field of biotherapeutic development.

We pursue this audacious vision because we believe in the unique and revolutionary power of generative biology to radically transform the lives of billions, with an outsized opportunity for patients in need. We are seeking collaborative, relentless problem solvers that share our passion for impact to join us!

Generate:

Biomedicines was founded in 2018 by Flagship Pioneering and has received nearly $700 million in funding, providing the resources to rapidly scale the organization. The Company has offices in Somerville and Andover, Massachusetts with 300+ employees.

We are seeking a highly collaborative and hands-on Senior Director / Executive Director, Investor Relations to help build and scale our investor relations function as a newly public biotechnology company. This role will serve as a close partner to the CFO and work cross-functionally with Strategy, Corporate Communications, Legal, Finance, Technology and R&D to translate our science, pipeline strategy, wet lab capabilities, and machine learning technology into clear, credible, and consistent communications for investors and analysts.

This role requires exceptional writing and executive communication skills, strong scientific curiosity and fluency, and the ability to operate with discipline and urgency in a public-company environment. The successful candidate will be comfortable drafting important external materials, building repeatable processes, and responding to investor and analyst questions with accuracy and strong judgment. While this role will not be expected to solely lead investor dialogue initially, it is designed to grow into increased external engagement over time.

This role is based in Somerville, MA and is expected to be onsite five days a week.

• Help establish scalable IR processes as a newly public company, including a disciplined quarterly calendar integrating close, filings, earnings releases and major milestones.
• Drive materials discipline and version control across all investor-facing content, ensuring consistent messaging across decks, scripts, Q&A, press releases, and web postings.
• Partner with Finance, Legal, and Communications to adhere to public-company guidelines and ensure strong execution under tight timelines.

• Draft and maintain key corporate and investor materials, including the corporate overview deck and conference presentations
• Support drafting of earnings-related communications, including press release language, earnings scripts, if relevant, and Q&A books in CEO/CFO/CSO/CMO/CTO voices.
• Translate complex experimental results and technical platform capabilities into clear “so what” investor language, backed by precise proof points and appropriate messaging boundaries.

• Serve as a key point person (with CFO oversight) for inbound investor and analyst questions, coordinating internally to source accurate answers and ensure consistent messaging.
• Prepare executives for investor and analyst engagements through pre-briefs, talking points, anticipated questions, and rehearsal support.
• Support analyst onboarding and teach-ins, initiation coordination, and follow-up communication in partnership with the CFO, Strategy, and Communications.

• Plan and execute conference preparation across content, logistics, rehearsal, and follow-up, ensuring high-quality materials and consistent messaging.
• Support meeting strategy…